In Vitro Studies to Evaluate the Intestinal Permeation of an Ursodeoxycholic Acid-Conjugated Oligonucleotide for Duchenne Muscular Dystrophy Treatment
Delivery represents a major hurdle to the clinical advancement of oligonucleotide therapeutics for the treatment of disorders such as Duchenne muscular dystrophy (DMD). In this preliminary study, we explored the ability of 2'-<i>O</i>-methyl-phosphorothioate antisense oligonucleotid...
Saved in:
Main Authors: | Marika Faiella (Author), Giada Botti (Author), Alessandro Dalpiaz (Author), Lorenzo Gnudi (Author), Aurélie Goyenvalle (Author), Barbara Pavan (Author), Daniela Perrone (Author), Matteo Bovolenta (Author), Elena Marchesi (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and Safety Profile of Tricyclo-DNA Antisense Oligonucleotides in Duchenne Muscular Dystrophy Mouse Model
by: Karima Relizani, et al.
Published: (2017) -
Emotional behavior and brain anatomy of the mdx52 mouse model of Duchenne muscular dystrophy
by: Amel Saoudi, et al.
Published: (2021) -
Evaluation of 2'-Deoxy-2'-fluoro Antisense Oligonucleotides for Exon Skipping in Duchenne Muscular Dystrophy
by: Silvana M G Jirka, et al.
Published: (2015) -
Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (1989) -
Prednisone in Duchenne Dystrophy
by: J Gordon Millichap
Published: (1991)